Here’s How to Become a TFSA Millionaire This Decade

It is possible to become a TFSA millionaire in the 2020s by targeting stocks like VieMed Healthcare Inc. (TSX:VMD)(NASDAQ:VMD) and others right now.

When the Tax-Free Savings Account (TFSA) first launched in January 2009, it took some serious magic for investors to accumulate hundreds of thousands in their account, let alone a million. Today, becoming a TFSA millionaire is still an incredible achievement. However, it is no longer a goal that is reserved for the craftiest among us.

The cumulative contribution room in a TFSA stands at $69,500 in 2020. With the right moves, it is not out of the question that TFSA investors can turn this into seven figures over the course of a decade.

TFSA millionaire: Get in on healthcare stocks!

All investors should be taking a hard look at healthcare stocks to kick off this decade. The healthcare space enjoyed good growth in the 2010s. Leaps in medicine and an aging population in North America will continue to contribute to its performance. Below are two healthcare stocks that have provided explosive growth in recent months. These equities can put you on the fast track to becoming a TFSA millionaire.

Trillium Therapeutics (TSX:TRIL)(NASDAQ:TRIL) is a clinical-stage immuno-oncology company that develops therapies for the treatment of cancer. As I’d mentioned, our aging society has resulted in increased demand for cancer treatments. Cancer is the leading cause of death in Canada.

Allied Market Research recently forecast that the global cancer therapeutics market would reach $180 billion by 2026. This would represent a CAGR of 7.7% from 2019 to the end of the projection period. Shares of Trillium Therapeutics have climbed over 2,000% year over year. A $5,000 investment in Trillium a year ago would be worth roughly $107,000 as of close on June 17. In this instance, we’re already 10% of the way to becoming a TFSA millionaire.

VieMed Healthcare has not been quite as explosive as Trillium over the past year, but its shareholders also have reason to celebrate. Shares of VieMed have shot up 212% over the past three months as of close on June 17.

Technology continues to offer massive growth

As far as growth is concerned, technology will continue to give healthcare a run for its money. The TSX index has attracted critics for its lack of exposure to this electric sector. It may not offer the breadth of options we see south of the border, but there are still some fantastic stocks in the Great White North.

Shopify has been a huge success story since its IPO back in 2015. Shares of the e-commerce giant have climbed 114% in 2020 so far. Those who got in early have a lot to celebrate. However, the stock dropped below the $500 mark in the middle of March. That means TSFA investors could have more than doubled their money in this stock in a few short months. Shopify will undoubtedly be in the portfolios of some TFSA millionaires this decade.

Demographic shifts can propel your portfolio

We have discussed the importance of jumping into promising sectors like healthcare and technology. Paying attention to demographic trends can also pay off in the long term. Jamieson Wellness is one TSX stock that will benefit from an aging population. Baby boomers are some of the biggest consumers of supplements and natural health products. Shares of Jamieson, a manufacturer and distributor of these products, have climbed 76% year over year.

Investors who want to enter the TFSA millionaire club should pay close attention to companies like Jamieson.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify, Shopify, and Viemed Healthcare Inc.

More on Investing

Confused person shrugging
Dividend Stocks

Passive Income: How Much Do You Need to Invest to Make $625 Per Month?

This retirement passive-income stock proves why investors need to always take into consideration not just dividends but returns as well.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

Secure Your Future: 3 Safe Canadian Dividend Stocks to Anchor Your Portfolio Long Term

Here are three of the safest Canadian dividend stocks you can consider adding to your portfolio right now to secure…

Read more »

money goes up and down in balance
Dividend Stocks

Is Fiera Capital Stock a Buy for its 8.6% Dividend Yield?

Down almost 40% from all-time highs, Fiera Capital stock offers you a tasty dividend yield right now. Is the TSX…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Wednesday, December 11

In addition to the U.S. inflation report, the Bank of Canada’s interest rate decision and press conference will remain on…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How to Use Your TFSA to Double Your TFSA Contribution

If you're looking to double up that TFSA contribution, there is one dividend stock I would certainly look to in…

Read more »

Income and growth financial chart
Investing

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

Amazon (NASDAQ:AMZN) is starting to run faster in the AI race, making it a top U.S. pick for 2025.

Read more »

Person uses a tablet in a blurred warehouse as background
Tech Stocks

2 Canadian AI Stocks Poised for Significant Gains

Here are two top AI stocks long-term investors may want to consider before the end of the year.

Read more »

man touches brain to show a good idea
Investing

3 No Brainer Tech Stocks to Buy With $500 Right Now

Here are three no-brainer tech stocks long-term investors on a limited budget may want to consider right now.

Read more »